Back to Jefferies Financial Group Inc. Jefferies Financial Group Inc.

TXG

11 quarters

Position history for Jefferies Financial Group Inc.Jefferies Financial Group Inc.'s holdings in 10x Genomics, Inc.

No. Jefferies Financial Group exited its TXG (10x Genomics) position in Q3 2026. Its Q2 2026 13F listed 29,000 shares worth $1.1M. Jefferies Financial Group first reported TXG in Q3 2023 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$255,173

Total Shares Change

-6,186

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$90.36
0
2026-Q2
Decreased
29,000
-48.0%
$1.1M0.0%$38.34
0
2026-Q1
Increased
55,800
+290.2%
$1.2M0.0%$21.23
41
2025-Q4
New
14,299
-
$233,2170.0%$16.31
32
2025-Q3
Exited
0
-100.0%
$00.0%$11.69
0
2025-Q2
Decreased
34,000
-52.4%
$393,7200.0%$11.58
0
2025-Q1
Increased
71,425
+130.1%
$623,5410.0%$8.73
39
2024-Q4
Decreased
31,048
-90.1%
$445,8490.0%$14.36
0
2024-Q3
New
315,048
-
$7.1M0.1%$22.58
38
2023-Q4
Exited
0
-100.0%
$00.0%$55.96
0
2023-Q3
New
6,186
-
$255,1730.0%$41.25
32

Other major holders of TXG: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used